Axsome Therapeutics, Inc.AXSMEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| RTW Investments, LP | 9.50% | 4.5M | — | 2024-02-14 |
| The Vanguard Group | 7.81% | 3.7M | — | 2024-02-13 |
| BlackRock, Inc. | 6.80% | 3.2M | — | 2024-01-26 |
| of Above Persons | 4.90% | 2.4M | ▼ -0.10pp | 2024-02-14 |
Insider Transactions
Net 90d: −$17.14M · buys $0 / sells $17.14MRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-22 | Ari Maizel | Chief Commercial Officer | Option exercise | 7.5K | $70.73 | $530.5K |
| 2026-04-22 | Ari Maizel | Chief Commercial Officer | Sell (open market) | 7.5K | $182.42 | $1.37M |
| 2026-02-26 | Mark Coleman | Director | Sell (open market) | 25.0K | $161.11 | $4.03M |
| 2026-02-26 | Jacobson Mark L. | Chief Operating Officer | Option exercise | 35.4K | $2.85 | $100.8K |
| 2026-02-26 | Jacobson Mark L. | Chief Operating Officer | Sell (open market) | 35.4K | $161.88 | $5.73M |
| 2026-02-23 | Mark Coleman | Director | Option exercise | 6.3K | $4.95 | $30.9K |
| 2026-02-20 | Mark Coleman | Director | Option exercise | 12.5K | $4.95 | $61.8K |
| 2026-02-10 | Mark Coleman | Director | Option exercise | 5.2K | $8.02 | $41.6K |
| 2026-02-02 | TABUTEAU HERRIOT | Chief Executive Officer | Option exercise | 32.4K | $8.02 | $259.9K |
| 2026-02-02 | TABUTEAU HERRIOT | Chief Executive Officer | Sell (open market) | 32.4K | $185.60 | $6.02M |
1–10 of 10